FDA eyes 1st schizophrenia drug in decades
FDA Lifts Clinical Hold On BMF-219
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results